New lead compounds identification against KRas mediated cancers through pharmacophore-based virtual screening and in vitro assays-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New lead compounds identification against KRas mediated cancers through pharmacophore-based virtual screening and in vitro assays

Published:2022-10-02 Issue: Volume: Page:1-15
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Ghufran Mehreen¹²,Rehman Ashfaq Ur³,Ayaz Muhammad⁴^ORCID,ul-Haq Zaheer⁵,Uddin Reaz⁵,Azam Syed Sikander⁶,Wadood Abdul¹

Affiliation:

1. Department of Biochemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan

2. Department of Pathology, Medical Teaching Institution Bacha Khan Medical College (BKMC) Mardan, Mardan, Pakistan

3. Department of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA

4. Department of Pharmacy, University of Malakand, Chakdara, Pakistan

5. Dr. Panjwani Center for Molecular Medicine and Drug Research, University of Karachi, Karachi, Pakistan

6. Department of Bioinformatics, Quaid-e-Azam University, Islamabad, Pakistan

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2128878

Reference74 articles.

1. The development of proteasome inhibitors as anticancer drugs

2. Development of the Proteasome Inhibitor Velcade™ (Bortezomib)

3. 6-Methoxyflavanone abates cisplatin-induced neuropathic pain apropos anti-inflammatory mechanisms: A behavioral and molecular simulation study

4. Molecularly Characterized Solvent Extracts and Saponins from Polygonum hydropiper L. Show High Anti-Angiogenic, Anti-Tumor, Brine Shrimp, and Fibroblast NIH/3T3 Cell Line Cytotoxicity

5. Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals with Cancer Chemotherapeutics: Potential Benefits and Risks

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential nanomedicinal applications and physicochemical nature of Hyphaene thebaica‐reduced nano‐samaria;Microscopy Research and Technique;2024-07-15

2. Identification of new potent NLRP3 inhibitors by multi-level in-silico approaches;BMC Chemistry;2024-04-18

3. In silico exploration of the potential inhibitory activities of in-house and ZINC database lead compounds against alpha-glucosidase using structure-based virtual screening and molecular dynamics simulation approach;Journal of Biomolecular Structure and Dynamics;2024-01-31

4. Phytochemical analysis, radical scavenging and glioblastoma U87 cells toxicity studies of stem bark of buckthorn (Rhamnus pentapomica R. Parker);BMC Complementary Medicine and Therapies;2024-01-02

5. Exploring potent aldose reductase inhibitors for anti-diabetic (anti-hyperglycemic) therapy: integrating structure-based drug design, and MMGBSA approaches;Frontiers in Molecular Biosciences;2023-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3